1 Study Coverage
    1.1 Rofecoxib Product Introduction
    1.2 Market by Type
        1.2.1 Global Rofecoxib Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Oral Suspension.
        1.2.3 Tablet-Form
    1.3 Market by Application
        1.3.1 Global Rofecoxib Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Osteoarthritis
        1.3.3 Rheumatoid Arthritis
        1.3.4 Juvenile Rheumatoid Arthritis
        1.3.5 Acute Pain Conditions
        1.3.6 Migraine
        1.3.7 Dysmenorrhea
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Rofecoxib Sales Estimates and Forecasts 2017-2028
    2.2 Global Rofecoxib Revenue Estimates and Forecasts 2017-2028
    2.3 Global Rofecoxib Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Rofecoxib Sales by Region
        2.4.1 Global Rofecoxib Sales by Region (2017-2022)
        2.4.2 Global Sales Rofecoxib by Region (2023-2028)
    2.5 Global Rofecoxib Revenue by Region
        2.5.1 Global Rofecoxib Revenue by Region (2017-2022)
        2.5.2 Global Rofecoxib Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Rofecoxib Sales by Manufacturers
        3.1.1 Global Top Rofecoxib Manufacturers by Sales (2017-2022)
        3.1.2 Global Rofecoxib Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Rofecoxib in 2021
    3.2 Global Rofecoxib Revenue by Manufacturers
        3.2.1 Global Rofecoxib Revenue by Manufacturers (2017-2022)
        3.2.2 Global Rofecoxib Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Rofecoxib Revenue in 2021
    3.3 Global Rofecoxib Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Rofecoxib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Rofecoxib Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Rofecoxib Sales by Type
        4.1.1 Global Rofecoxib Historical Sales by Type (2017-2022)
        4.1.2 Global Rofecoxib Forecasted Sales by Type (2023-2028)
        4.1.3 Global Rofecoxib Sales Market Share by Type (2017-2028)
    4.2 Global Rofecoxib Revenue by Type
        4.2.1 Global Rofecoxib Historical Revenue by Type (2017-2022)
        4.2.2 Global Rofecoxib Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Rofecoxib Revenue Market Share by Type (2017-2028)
    4.3 Global Rofecoxib Price by Type
        4.3.1 Global Rofecoxib Price by Type (2017-2022)
        4.3.2 Global Rofecoxib Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Rofecoxib Sales by Application
        5.1.1 Global Rofecoxib Historical Sales by Application (2017-2022)
        5.1.2 Global Rofecoxib Forecasted Sales by Application (2023-2028)
        5.1.3 Global Rofecoxib Sales Market Share by Application (2017-2028)
    5.2 Global Rofecoxib Revenue by Application
        5.2.1 Global Rofecoxib Historical Revenue by Application (2017-2022)
        5.2.2 Global Rofecoxib Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Rofecoxib Revenue Market Share by Application (2017-2028)
    5.3 Global Rofecoxib Price by Application
        5.3.1 Global Rofecoxib Price by Application (2017-2022)
        5.3.2 Global Rofecoxib Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Rofecoxib Market Size by Type
        6.1.1 North America Rofecoxib Sales by Type (2017-2028)
        6.1.2 North America Rofecoxib Revenue by Type (2017-2028)
    6.2 North America Rofecoxib Market Size by Application
        6.2.1 North America Rofecoxib Sales by Application (2017-2028)
        6.2.2 North America Rofecoxib Revenue by Application (2017-2028)
    6.3 North America Rofecoxib Market Size by Country
        6.3.1 North America Rofecoxib Sales by Country (2017-2028)
        6.3.2 North America Rofecoxib Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Rofecoxib Market Size by Type
        7.1.1 Europe Rofecoxib Sales by Type (2017-2028)
        7.1.2 Europe Rofecoxib Revenue by Type (2017-2028)
    7.2 Europe Rofecoxib Market Size by Application
        7.2.1 Europe Rofecoxib Sales by Application (2017-2028)
        7.2.2 Europe Rofecoxib Revenue by Application (2017-2028)
    7.3 Europe Rofecoxib Market Size by Country
        7.3.1 Europe Rofecoxib Sales by Country (2017-2028)
        7.3.2 Europe Rofecoxib Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Rofecoxib Market Size by Type
        8.1.1 Asia Pacific Rofecoxib Sales by Type (2017-2028)
        8.1.2 Asia Pacific Rofecoxib Revenue by Type (2017-2028)
    8.2 Asia Pacific Rofecoxib Market Size by Application
        8.2.1 Asia Pacific Rofecoxib Sales by Application (2017-2028)
        8.2.2 Asia Pacific Rofecoxib Revenue by Application (2017-2028)
    8.3 Asia Pacific Rofecoxib Market Size by Region
        8.3.1 Asia Pacific Rofecoxib Sales by Region (2017-2028)
        8.3.2 Asia Pacific Rofecoxib Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Rofecoxib Market Size by Type
        9.1.1 Latin America Rofecoxib Sales by Type (2017-2028)
        9.1.2 Latin America Rofecoxib Revenue by Type (2017-2028)
    9.2 Latin America Rofecoxib Market Size by Application
        9.2.1 Latin America Rofecoxib Sales by Application (2017-2028)
        9.2.2 Latin America Rofecoxib Revenue by Application (2017-2028)
    9.3 Latin America Rofecoxib Market Size by Country
        9.3.1 Latin America Rofecoxib Sales by Country (2017-2028)
        9.3.2 Latin America Rofecoxib Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Rofecoxib Market Size by Type
        10.1.1 Middle East and Africa Rofecoxib Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Rofecoxib Revenue by Type (2017-2028)
    10.2 Middle East and Africa Rofecoxib Market Size by Application
        10.2.1 Middle East and Africa Rofecoxib Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Rofecoxib Revenue by Application (2017-2028)
    10.3 Middle East and Africa Rofecoxib Market Size by Country
        10.3.1 Middle East and Africa Rofecoxib Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Rofecoxib Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Merck
        11.1.1 Merck Corporation Information
        11.1.2 Merck Overview
        11.1.3 Merck Rofecoxib Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Merck Rofecoxib Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Merck Recent Developments
    11.2 Chengdu Meinkai Chemical Co. LTD
        11.2.1 Chengdu Meinkai Chemical Co. LTD Corporation Information
        11.2.2 Chengdu Meinkai Chemical Co. LTD Overview
        11.2.3 Chengdu Meinkai Chemical Co. LTD Rofecoxib Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Chengdu Meinkai Chemical Co. LTD Rofecoxib Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Chengdu Meinkai Chemical Co. LTD Recent Developments
    11.3 Wuhan Xinxin Jiali Biotechnology Co. LTD
        11.3.1 Wuhan Xinxin Jiali Biotechnology Co. LTD Corporation Information
        11.3.2 Wuhan Xinxin Jiali Biotechnology Co. LTD Overview
        11.3.3 Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Wuhan Xinxin Jiali Biotechnology Co. LTD Recent Developments
    11.4 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD
        11.4.1 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Corporation Information
        11.4.2 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Overview
        11.4.3 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Recent Developments
    11.5 Pfizer
        11.5.1 Pfizer Corporation Information
        11.5.2 Pfizer Overview
        11.5.3 Pfizer Rofecoxib Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Pfizer Rofecoxib Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Pfizer Recent Developments
    11.6 Tremeau
        11.6.1 Tremeau Corporation Information
        11.6.2 Tremeau Overview
        11.6.3 Tremeau Rofecoxib Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Tremeau Rofecoxib Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Tremeau Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Rofecoxib Industry Chain Analysis
    12.2 Rofecoxib Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Rofecoxib Production Mode & Process
    12.4 Rofecoxib Sales and Marketing
        12.4.1 Rofecoxib Sales Channels
        12.4.2 Rofecoxib Distributors
    12.5 Rofecoxib Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Rofecoxib Industry Trends
    13.2 Rofecoxib Market Drivers
    13.3 Rofecoxib Market Challenges
    13.4 Rofecoxib Market Restraints
14 Key Findings in The Global Rofecoxib Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Rofecoxib Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Oral Suspension.
    Table 3. Major Manufacturers of Tablet-Form
    Table 4. Global Rofecoxib Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Rofecoxib Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Rofecoxib Sales by Region (2017-2022) & (MT)
    Table 7. Global Rofecoxib Sales Market Share by Region (2017-2022)
    Table 8. Global Rofecoxib Sales by Region (2023-2028) & (MT)
    Table 9. Global Rofecoxib Sales Market Share by Region (2023-2028)
    Table 10. Global Rofecoxib Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Rofecoxib Revenue Market Share by Region (2017-2022)
    Table 12. Global Rofecoxib Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Rofecoxib Revenue Market Share by Region (2023-2028)
    Table 14. Global Rofecoxib Sales by Manufacturers (2017-2022) & (MT)
    Table 15. Global Rofecoxib Sales Share by Manufacturers (2017-2022)
    Table 16. Global Rofecoxib Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Rofecoxib Revenue Share by Manufacturers (2017-2022)
    Table 18. Rofecoxib Price by Manufacturers (2017-2022) &(USD/MT)
    Table 19. Global Rofecoxib Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Rofecoxib by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rofecoxib as of 2021)
    Table 21. Rofecoxib Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Rofecoxib Product Offered
    Table 23. Date of Manufacturers Enter into Rofecoxib Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Rofecoxib Sales by Type (2017-2022) & (MT)
    Table 26. Global Rofecoxib Sales by Type (2023-2028) & (MT)
    Table 27. Global Rofecoxib Sales Share by Type (2017-2022)
    Table 28. Global Rofecoxib Sales Share by Type (2023-2028)
    Table 29. Global Rofecoxib Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Rofecoxib Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Rofecoxib Revenue Share by Type (2017-2022)
    Table 32. Global Rofecoxib Revenue Share by Type (2023-2028)
    Table 33. Rofecoxib Price by Type (2017-2022) & (USD/MT)
    Table 34. Global Rofecoxib Price Forecast by Type (2023-2028) & (USD/MT)
    Table 35. Global Rofecoxib Sales by Application (2017-2022) & (MT)
    Table 36. Global Rofecoxib Sales by Application (2023-2028) & (MT)
    Table 37. Global Rofecoxib Sales Share by Application (2017-2022)
    Table 38. Global Rofecoxib Sales Share by Application (2023-2028)
    Table 39. Global Rofecoxib Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Rofecoxib Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Rofecoxib Revenue Share by Application (2017-2022)
    Table 42. Global Rofecoxib Revenue Share by Application (2023-2028)
    Table 43. Rofecoxib Price by Application (2017-2022) & (USD/MT)
    Table 44. Global Rofecoxib Price Forecast by Application (2023-2028) & (USD/MT)
    Table 45. North America Rofecoxib Sales by Type (2017-2022) & (MT)
    Table 46. North America Rofecoxib Sales by Type (2023-2028) & (MT)
    Table 47. North America Rofecoxib Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Rofecoxib Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Rofecoxib Sales by Application (2017-2022) & (MT)
    Table 50. North America Rofecoxib Sales by Application (2023-2028) & (MT)
    Table 51. North America Rofecoxib Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Rofecoxib Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Rofecoxib Sales by Country (2017-2022) & (MT)
    Table 54. North America Rofecoxib Sales by Country (2023-2028) & (MT)
    Table 55. North America Rofecoxib Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Rofecoxib Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Rofecoxib Sales by Type (2017-2022) & (MT)
    Table 58. Europe Rofecoxib Sales by Type (2023-2028) & (MT)
    Table 59. Europe Rofecoxib Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Rofecoxib Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Rofecoxib Sales by Application (2017-2022) & (MT)
    Table 62. Europe Rofecoxib Sales by Application (2023-2028) & (MT)
    Table 63. Europe Rofecoxib Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Rofecoxib Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Rofecoxib Sales by Country (2017-2022) & (MT)
    Table 66. Europe Rofecoxib Sales by Country (2023-2028) & (MT)
    Table 67. Europe Rofecoxib Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Rofecoxib Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Rofecoxib Sales by Type (2017-2022) & (MT)
    Table 70. Asia Pacific Rofecoxib Sales by Type (2023-2028) & (MT)
    Table 71. Asia Pacific Rofecoxib Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Rofecoxib Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Rofecoxib Sales by Application (2017-2022) & (MT)
    Table 74. Asia Pacific Rofecoxib Sales by Application (2023-2028) & (MT)
    Table 75. Asia Pacific Rofecoxib Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Rofecoxib Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Rofecoxib Sales by Region (2017-2022) & (MT)
    Table 78. Asia Pacific Rofecoxib Sales by Region (2023-2028) & (MT)
    Table 79. Asia Pacific Rofecoxib Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Rofecoxib Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Rofecoxib Sales by Type (2017-2022) & (MT)
    Table 82. Latin America Rofecoxib Sales by Type (2023-2028) & (MT)
    Table 83. Latin America Rofecoxib Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Rofecoxib Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Rofecoxib Sales by Application (2017-2022) & (MT)
    Table 86. Latin America Rofecoxib Sales by Application (2023-2028) & (MT)
    Table 87. Latin America Rofecoxib Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Rofecoxib Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Rofecoxib Sales by Country (2017-2022) & (MT)
    Table 90. Latin America Rofecoxib Sales by Country (2023-2028) & (MT)
    Table 91. Latin America Rofecoxib Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Rofecoxib Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Rofecoxib Sales by Type (2017-2022) & (MT)
    Table 94. Middle East and Africa Rofecoxib Sales by Type (2023-2028) & (MT)
    Table 95. Middle East and Africa Rofecoxib Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Rofecoxib Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Rofecoxib Sales by Application (2017-2022) & (MT)
    Table 98. Middle East and Africa Rofecoxib Sales by Application (2023-2028) & (MT)
    Table 99. Middle East and Africa Rofecoxib Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Rofecoxib Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Rofecoxib Sales by Country (2017-2022) & (MT)
    Table 102. Middle East and Africa Rofecoxib Sales by Country (2023-2028) & (MT)
    Table 103. Middle East and Africa Rofecoxib Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Rofecoxib Revenue by Country (2023-2028) & (US$ Million)
    Table 105. Merck Corporation Information
    Table 106. Merck Description and Major Businesses
    Table 107. Merck Rofecoxib Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 108. Merck Rofecoxib Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. Merck Recent Developments
    Table 110. Chengdu Meinkai Chemical Co. LTD Corporation Information
    Table 111. Chengdu Meinkai Chemical Co. LTD Description and Major Businesses
    Table 112. Chengdu Meinkai Chemical Co. LTD Rofecoxib Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 113. Chengdu Meinkai Chemical Co. LTD Rofecoxib Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. Chengdu Meinkai Chemical Co. LTD Recent Developments
    Table 115. Wuhan Xinxin Jiali Biotechnology Co. LTD Corporation Information
    Table 116. Wuhan Xinxin Jiali Biotechnology Co. LTD Description and Major Businesses
    Table 117. Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 118. Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Wuhan Xinxin Jiali Biotechnology Co. LTD Recent Developments
    Table 120. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Corporation Information
    Table 121. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Description and Major Businesses
    Table 122. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 123. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Recent Developments
    Table 125. Pfizer Corporation Information
    Table 126. Pfizer Description and Major Businesses
    Table 127. Pfizer Rofecoxib Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 128. Pfizer Rofecoxib Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. Pfizer Recent Developments
    Table 130. Tremeau Corporation Information
    Table 131. Tremeau Description and Major Businesses
    Table 132. Tremeau Rofecoxib Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 133. Tremeau Rofecoxib Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. Tremeau Recent Developments
    Table 135. Key Raw Materials Lists
    Table 136. Raw Materials Key Suppliers Lists
    Table 137. Rofecoxib Distributors List
    Table 138. Rofecoxib Customers List
    Table 139. Rofecoxib Market Trends
    Table 140. Rofecoxib Market Drivers
    Table 141. Rofecoxib Market Challenges
    Table 142. Rofecoxib Market Restraints
    Table 143. Research Programs/Design for This Report
    Table 144. Key Data Information from Secondary Sources
    Table 145. Key Data Information from Primary Sources
List of Figures
    Figure 1. Rofecoxib Product Picture
    Figure 3. Global Rofecoxib Market Share by Type in 2021 & 2028
    Figure 3. Oral Suspension. Product Picture
    Figure 4. Tablet-Form Product Picture
    Figure 5. Global Rofecoxib Market Share by Application in 2021 & 2028
    Figure 6. Osteoarthritis
    Figure 7. Rheumatoid Arthritis
    Figure 8. Juvenile Rheumatoid Arthritis
    Figure 9. Acute Pain Conditions
    Figure 10. Migraine
    Figure 11. Dysmenorrhea
    Figure 12. Rofecoxib Report Years Considered
    Figure 13. Global Rofecoxib Sales 2017-2028 (MT)
    Figure 14. Global Rofecoxib Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Rofecoxib Revenue 2017-2028 (US$ Million)
    Figure 16. Global Rofecoxib Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 17. Global Rofecoxib Sales Market Share by Region (2017-2022)
    Figure 18. Global Rofecoxib Sales Market Share by Region (2023-2028)
    Figure 19. North America Rofecoxib Sales YoY (2017-2028) & (MT)
    Figure 20. North America Rofecoxib Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Europe Rofecoxib Sales YoY (2017-2028) & (MT)
    Figure 22. Europe Rofecoxib Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Asia-Pacific Rofecoxib Sales YoY (2017-2028) & (MT)
    Figure 24. Asia-Pacific Rofecoxib Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Latin America Rofecoxib Sales YoY (2017-2028) & (MT)
    Figure 26. Latin America Rofecoxib Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. Middle East & Africa Rofecoxib Sales YoY (2017-2028) & (MT)
    Figure 28. Middle East & Africa Rofecoxib Revenue YoY (2017-2028) & (US$ Million)
    Figure 29. The Rofecoxib Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 30. The Top 5 and 10 Largest Manufacturers of Rofecoxib in the World: Market Share by Rofecoxib Revenue in 2021
    Figure 31. Global Rofecoxib Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 32. Global Rofecoxib Sales Market Share by Type (2017-2028)
    Figure 33. Global Rofecoxib Revenue Market Share by Type (2017-2028)
    Figure 34. Global Rofecoxib Sales Market Share by Application (2017-2028)
    Figure 35. Global Rofecoxib Revenue Market Share by Application (2017-2028)
    Figure 36. North America Rofecoxib Sales Market Share by Type (2017-2028)
    Figure 37. North America Rofecoxib Revenue Market Share by Type (2017-2028)
    Figure 38. North America Rofecoxib Sales Market Share by Application (2017-2028)
    Figure 39. North America Rofecoxib Revenue Market Share by Application (2017-2028)
    Figure 40. North America Rofecoxib Sales Share by Country (2017-2028)
    Figure 41. North America Rofecoxib Revenue Share by Country (2017-2028)
    Figure 42. U.S. Rofecoxib Revenue (2017-2028) & (US$ Million)
    Figure 43. Canada Rofecoxib Revenue (2017-2028) & (US$ Million)
    Figure 44. Europe Rofecoxib Sales Market Share by Type (2017-2028)
    Figure 45. Europe Rofecoxib Revenue Market Share by Type (2017-2028)
    Figure 46. Europe Rofecoxib Sales Market Share by Application (2017-2028)
    Figure 47. Europe Rofecoxib Revenue Market Share by Application (2017-2028)
    Figure 48. Europe Rofecoxib Sales Share by Country (2017-2028)
    Figure 49. Europe Rofecoxib Revenue Share by Country (2017-2028)
    Figure 50. Germany Rofecoxib Revenue (2017-2028) & (US$ Million)
    Figure 51. France Rofecoxib Revenue (2017-2028) & (US$ Million)
    Figure 52. U.K. Rofecoxib Revenue (2017-2028) & (US$ Million)
    Figure 53. Italy Rofecoxib Revenue (2017-2028) & (US$ Million)
    Figure 54. Russia Rofecoxib Revenue (2017-2028) & (US$ Million)
    Figure 55. Asia Pacific Rofecoxib Sales Market Share by Type (2017-2028)
    Figure 56. Asia Pacific Rofecoxib Revenue Market Share by Type (2017-2028)
    Figure 57. Asia Pacific Rofecoxib Sales Market Share by Application (2017-2028)
    Figure 58. Asia Pacific Rofecoxib Revenue Market Share by Application (2017-2028)
    Figure 59. Asia Pacific Rofecoxib Sales Share by Region (2017-2028)
    Figure 60. Asia Pacific Rofecoxib Revenue Share by Region (2017-2028)
    Figure 61. China Rofecoxib Revenue (2017-2028) & (US$ Million)
    Figure 62. Japan Rofecoxib Revenue (2017-2028) & (US$ Million)
    Figure 63. South Korea Rofecoxib Revenue (2017-2028) & (US$ Million)
    Figure 64. India Rofecoxib Revenue (2017-2028) & (US$ Million)
    Figure 65. Australia Rofecoxib Revenue (2017-2028) & (US$ Million)
    Figure 66. Taiwan Rofecoxib Revenue (2017-2028) & (US$ Million)
    Figure 67. Indonesia Rofecoxib Revenue (2017-2028) & (US$ Million)
    Figure 68. Thailand Rofecoxib Revenue (2017-2028) & (US$ Million)
    Figure 69. Malaysia Rofecoxib Revenue (2017-2028) & (US$ Million)
    Figure 70. Philippines Rofecoxib Revenue (2017-2028) & (US$ Million)
    Figure 71. Latin America Rofecoxib Sales Market Share by Type (2017-2028)
    Figure 72. Latin America Rofecoxib Revenue Market Share by Type (2017-2028)
    Figure 73. Latin America Rofecoxib Sales Market Share by Application (2017-2028)
    Figure 74. Latin America Rofecoxib Revenue Market Share by Application (2017-2028)
    Figure 75. Latin America Rofecoxib Sales Share by Country (2017-2028)
    Figure 76. Latin America Rofecoxib Revenue Share by Country (2017-2028)
    Figure 77. Mexico Rofecoxib Revenue (2017-2028) & (US$ Million)
    Figure 78. Brazil Rofecoxib Revenue (2017-2028) & (US$ Million)
    Figure 79. Argentina Rofecoxib Revenue (2017-2028) & (US$ Million)
    Figure 80. Middle East and Africa Rofecoxib Sales Market Share by Type (2017-2028)
    Figure 81. Middle East and Africa Rofecoxib Revenue Market Share by Type (2017-2028)
    Figure 82. Middle East and Africa Rofecoxib Sales Market Share by Application (2017-2028)
    Figure 83. Middle East and Africa Rofecoxib Revenue Market Share by Application (2017-2028)
    Figure 84. Middle East and Africa Rofecoxib Sales Share by Country (2017-2028)
    Figure 85. Middle East and Africa Rofecoxib Revenue Share by Country (2017-2028)
    Figure 86. Turkey Rofecoxib Revenue (2017-2028) & (US$ Million)
    Figure 87. Saudi Arabia Rofecoxib Revenue (2017-2028) & (US$ Million)
    Figure 88. U.A.E Rofecoxib Revenue (2017-2028) & (US$ Million)
    Figure 89. Rofecoxib Value Chain
    Figure 90. Rofecoxib Production Process
    Figure 91. Channels of Distribution
    Figure 92. Distributors Profiles
    Figure 93. Bottom-up and Top-down Approaches for This Report
    Figure 94. Data Triangulation
    Figure 95. Key Executives Interviewed